Leica Microsystems and Leica Biosystems Strengthen Market Position in Brazil
News Apr 23, 2013
Leica Microsystems and Leica Biosystems have cemented ties with their Brazilian Leica distributor: All shares of Aotec Instrumentos Cientificos Ltda of São Paulo, Brazil, have been acquired. Aotec is a provider of microscopy and histopathology solutions and has been a Leica distributor for more than 25 years. All Aotec associates will remain with Aotec. Furthermore, the company is actively hiring additional staff to enlarge the Brazilian teams. Leica Microsystems and Leica Biosystems thereby strengthen their market position.
“Brazil is a very important market. Through this acquisition we are developing our business further and invest into the service to our customers,” says Dr. Jürgen Kress, Senior Sales Director High Growth Markets, Leica Biosystems. “As a long-standing business partner for Leica, Aotec has established stable customer relationships on behalf of our companies. Their expertise is highly valued – the associates possess a deep knowledge of the Brazilian market and have provided services of outstanding quality to our customers,” says Yves Janin, Managing Director Distributors Sales Area, Leica Microsystems.
Having been founded as a family business in the 19th century, Leica Microsystems has a tradition of developing and evolving high precision optics and scientific instruments “with the user, for the user”. “We work with our customers to ensure that our products and services are tailor-made. Now, we will work even closer with our Brazilian customers to meet their requirements,” says Janin. “The same applies to Leica Biosystems. We offer our customers instruments, consumables and reagents for the entire workflow, so they benefit from having a single source for all their histopathology needs”, says Kress.
“We are looking forward to continuing our excellent service to our customers and to developing the Brazilian business,” says Luis Roberto Mesquita who owned Aotec together with his brother Carlos Mesquita and his nephew Marcio Mesquita.
The current management teams will work on the integration of the businesses and operate from the existing headquarters in Sao Paulo.
‘Mini Tumors’ from Patient Samples Could Help Personalize Cancer Drug TreatmentNews
Testing cancer drugs on miniature replicas of a patient’s tumour could help doctors tell in advance which treatments will work, a major new study reports.READ MORE
Minoryx Therapeutics spins off SEE-Tx platform into new company, Gain TherapeuticsNews
The new Swiss company will operate in Lugano and Barcelona under the scientific management of Minoryx co-founder Dr Xavier Barril.READ MORE
Sequencing Shows How Evolution Can Undermine Bioprocess CommercializationNews
Rapid evolution can suppress the effect of pro-production genes in biochemical processes.READ MORE
Comments | 0 ADD COMMENT
World Advanced Therapies & Regenerative Medicine Congress
May 16 - May 18, 2018